Companion Animals

Dog Canine Myasthenia Gravis Welfare

Myasthenia gravis causes progressive muscle weakness in affected dogs, with welfare managed through early diagnosis and immunosuppressive treatment.

Key Facts

Myasthenia gravis is an autoimmune disease that blocks neuromuscular transmission
Acquired myasthenia gravis is most common in Labrador Retrievers and German Shepherds
Regurgitation due to megaoesophagus is the most common and life-threatening complication
Aspiration pneumonia from regurgitation causes significant morbidity and mortality
Anticholinesterase therapy improves muscle function; immunosuppression treats the underlying disease

Welfare Considerations

Dogs with myasthenia gravis experience profound weakness, difficulty swallowing, and risk of aspiration pneumonia. Early diagnosis and appropriate management allow many dogs to achieve remission and good quality of life.

What You Can Do

Seek prompt veterinary assessment if your dog develops sudden weakness or difficulty swallowing
Manage megaoesophagus through upright feeding to reduce aspiration risk
Support research into better treatments for acquired myasthenia gravis in dogs